china exposure

The China variable in earnings guidance

Companies flagged here are explicitly discussing China exposure — supply chain dependency, revenue at risk from tariffs, or growth opportunities in the market. The geopolitical uncertainty makes this a recurring wildcard in forward guidance.

Companies
7
Combined Revenue
$147.0B
Avg YoY Growth
+4%
Signal Breakdown
TAILWIND2
MIXED4
HEADWIND1

What Executives Are Saying

Today, we are proud to report a June quarter revenue record of $94 billion, up 10% from a year ago, which was better than we expected. EPS set a June quarter record of $1.57, up 12% year over year.
Tim Cook, CEO Apple Inc.
growth-signalguidance
We see AI as one of the most profound technologies of our lifetime. We are embedding it across our devices and platforms and across the company. We are also significantly growing our investments.
Tim Cook, CEO Apple Inc.
aistrategy
In terms of pull forward, we would estimate the pull forward of demand into April specifically to be about one point of the 10 points in terms of people buying because of discussions about tariffs.
Tim Cook, CEO Apple Inc.
tariffsgrowth-signal
The vast majority of the iPhones sold in the U.S. have a country of origin of India. And the vast majority of the other products, the Macs, iPad and Watch have a country of origin of Vietnam.
Tim Cook, CEO Apple Inc.
supply-chaintariffs
We're making good progress on a more personalized Siri, and we do expect to release the features next year. We are significantly growing our investment.
Tim Cook, CEO Apple Inc.
aiguidance
We expect our September quarter total company revenue to grow mid to high single digits year over year. We expect services revenue to grow at a year over year rate similar to what we reported in the June quarter.
Kevin Parekh, CFO Apple Inc.
guidance

Companies in This Theme

AAPLApple Inc. · Q3-2025Information Technology
TAILWIND
Rev$94.0B
YoY+10%
EPS$1.57

Record June quarter at $94B with broad-based growth. iPhone up 13% with a June quarter upgrader record. Services hit all-time high at $27.4B. Tariff headwind is real at $800M this quarter and $1.1B projected next quarter, but Apple is absorbing it within strong margins.

APTVAptiv plc · Q3-2025Consumer Discretionary
MIXED
Rev$20.3B
YoY+3%
EPS$7.70

Aptiv is splitting into two public companies to unlock value. New Aptiv (Intelligent Systems + Engineered Components) targets 4-7% revenue growth and ~21% EBITDA margins by 2028. The EDS spin-off signals automotive supplier maturity — growth is moderating to 3-4%, and the company is pivoting hard into non-auto end markets like aerospace, telecom, and industrial AI at the edge.

MRKMerck & Co. Inc. · Q3-2025Health Care
MIXED
Rev$17.3B
YoY+4%
EPS$2.58

KEYTRUDA franchise keeps powering ahead at 10% growth, and WINREVAIR's 141% ramp is validating the cardiovascular expansion thesis. But GARDASIL's 24% decline in China is a structural headwind, not a blip. The $70B+ domestic manufacturing commitment signals long-term confidence but compresses near-term margins.

QCOMQualcomm Inc. · Q3-2025Information Technology
TAILWIND
Rev$11.3B
YoY+10%
EPS$3.00

Qualcomm posted record QCT revenues with 18% non-Apple growth and 27% combined Automotive+IoT growth. They're expanding into data centers and advanced robotics — new TAM that didn't exist two years ago. The Automotive pipeline is accelerating with their automated driving stack now available.

APDAir Products and Chemicals Inc. · Q3-2025Materials
MIXED
Rev$3.2B
YoY-1%
EPS$0.02

Air Products is in strategic reset mode — exiting $3.7B in clean energy projects, cutting costs globally, and refocusing on core industrial gases. Europe is the bright spot with 15% operating income growth. Americas margins compressed 380bps on higher maintenance costs and volume loss.

ALGNAlign Technology Inc. · Q3-2025Health Care
MIXED
Rev$996M
YoY+2%
EPS$0.78

Orthodontic and dental markets remain mixed, especially in North America. International markets (EMEA, APAC, LatAm) are driving volume growth. Restructuring charges of $88M signal serious cost-cutting underway while teens/kids category is a bright spot at 8.3% YoY growth.

CECelanese Corp. · Q3-2025Materials
HEADWIND
Rev
YoY
EPS$1.34

Celanese is in full-on cash preservation and deleveraging mode against a macro backdrop that refuses to improve. Sequential net sales declined 4%, auto builds fell 2%, and consumer/medical/industrial demand remains below normal. The only bright spots are self-help cost cuts and inventory discipline — not demand recovery.

Competitor Mentions Across This Theme

CompetitorMentionsBySentiment
Wind River151 companyBULLISH
Google42 companiesCAUTIOUS
LaNova Medicines41 companyNEUTRAL
AstraZeneca31 companyNEUTRAL
Daiichi Sankyo31 companyBULLISH
Verona Pharma31 companyBULLISH
Epic21 companyCAUTIOUS
MP Materials21 companyBULLISH
Top Citation

Wind River Studio tools for ADAS ML stack development, OTA updates, and data harvesting

— on Wind River

Operator Implications

Apple Inc. TAILWIND

Apple's installed base hit all-time highs across every product and geo segment. If you're building on Apple platforms, your addressable market is expanding. But watch the tariff math — $1.1B in projected Q4 costs means Apple may eventually pass costs to consumers or squeeze supplier margins. The AI investment acceleration is real: CapEx is growing substantially with AI as the primary driver.

Aptiv plc MIXED

If you sell into automotive OEMs, budget cycles are getting longer and more complex as suppliers like Aptiv restructure. But if you build edge AI, robotics, or industrial automation solutions, Aptiv's aggressive pivot into non-auto markets signals real demand from a $12B+ buyer willing to invest organically and via M&A.

Merck & Co. Inc. MIXED

If you're selling into pharma or hospital systems, KEYTRUDA subcutaneous approval (one-minute administration) is about to reshape infusion center economics — watch for procurement cycle changes in oncology clinics.

Qualcomm Inc. TAILWIND

If you're building on edge compute or automotive platforms, Qualcomm's investment in automated driving and data center expansion signals a deepening ecosystem — expect more integration points and developer tools in the next 12 months.

Air Products and Chemicals Inc. MIXED

If you're selling into industrial gas or clean energy infrastructure, expect delayed timelines and tighter vendor scrutiny as APD rationalizes its project portfolio. Their $4B capex plan for FY2026 signals continued spending but with far more discipline on returns.

Align Technology Inc. MIXED

If you're selling into dental or orthodontic practices, expect North American budgets to stay tight. International expansion and pediatric/teen segments are where the growth is — orient your GTM accordingly.

Celanese Corp. HEADWIND

If you sell into any Celanese end-market — auto, industrial, construction, coatings — budget cycles are frozen. Their entire strategy is cost-cutting and deleveraging, not growth investment. Don't expect procurement teams at materials companies to greenlight new vendor relationships until demand visibly turns.